MEDPLUS logo

MedPlus Health Services Limited Stock Price

NSEI:MEDPLUS Community·₹103.1b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

MEDPLUS Share Price Performance

₹858.70
-56.45 (-6.17%)
₹1,168.71
Fair Value
₹858.70
-56.45 (-6.17%)
26.5% undervalued intrinsic discount
₹1,168.71
Fair Value
Price ₹858.70
AnalystConsensusTarget ₹1,168.71

MEDPLUS Community Narratives

·
Fair Value ₹1.17k 26.5% undervalued intrinsic discount

Diagnostics Expansion And Private Labels Will Strengthen Market Position

1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative

Trending Discussion

Updated Narratives

MEDPLUS logo

MEDPLUS: CSR Subsidiary And AGM Timeline Will Support Bullish Repricing

Fair Value: ₹1.17k 26.5% undervalued intrinsic discount
7 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
3 Rewards

MedPlus Health Services Limited Key Details

₹68.9b

Revenue

₹50.8b

Cost of Revenue

₹18.1b

Gross Profit

₹15.9b

Other Expenses

₹2.2b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
18.30
26.23%
3.19%
0%
View Full Analysis

About MEDPLUS

Founded
2006
Employees
25007
CEO
Gangadi Reddy
WebsiteView website
www.medplusindia.com

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.

Recent MEDPLUS News & Updates

Narrative Update Jun 04

MEDPLUS: CSR Subsidiary And AGM Timeline Will Support Bullish Repricing

Analysts have raised the price target on MedPlus Health Services from ₹1,059.71 to ₹1,168.71, citing updated assumptions around revenue growth, profit margins, discount rate, and expected future P/E. What's in the News A board meeting is scheduled for May 20, 2026, at 14:00 IST to consider and approve audited standalone and consolidated financial results for the quarter and full year ended March 31, 2026.
Analysis Article May 28

MedPlus Health Services' (NSE:MEDPLUS) Strong Earnings Are Of Good Quality

The subdued stock price reaction suggests that MedPlus Health Services Limited's ( NSE:MEDPLUS ) strong earnings didn't...

Recent updates

No updates